Scarica l'app Stockscreener
1.29
4.03%
0.05
Pre-mercato:
1.23
-0.06
-4.65%
Pmv Pharmaceuticals Inc Borsa (PMVP) Ultime notizie
PMV Pharmaceuticals stock gains as biotech peers advance - AD HOC NEWS
Pmv Pharmaceuticals Inc (NASDAQ: PMVP) Share Price, PMVP Stock News, PMVP Share Price & Updates - kalkine.com.au
PMV Pharmaceuticals stock gains on HC Wainwright buy rating and 5 dollar target - AD HOC NEWS
PMVP Reiterated by HC Wainwright & Co. -- Price Target Maintained at $5.00 - GuruFocus
PMV Pharmaceuticals Prices Oversubscribed $50.8 Million Offering - TipRanks
PMV Pharma Raises $50.8 Million to Fuel Cancer Drug Push - Yahoo Finance
PMV Pharmaceuticals (PMVP) Announces $50.8M Oversubscribed Offering Amid Mixed Market Signals - GuruFocus
PMV Pharma Prices $50.8 Million Public Offering of Common Stock, Pre-Funded Warrants and Accompanying Warrants - Quiver Quantitative
PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities - GlobeNewswire
PMV Pharmaceuticals (PMVP) Launches Public Offering Amid Unprofi - GuruFocus
PMV Pharmaceuticals Highlights Promising Phase 2 Ovarian Data - TipRanks
PMV Pharmaceuticals reports 46% ORR in ovarian cohort, plans NDA filing in Q1 2027 - TradingView
PMV Pharma Announces Proposed Public Offering of Securities - GlobeNewswire
PMV Pharmaceuticals Announces Updated Promising Rezatapopt Monotherapy Interim Ovarian Cancer Data From PYNNACLE Phase 2 Pivotal Trial - Yahoo Finance
Ovarian cancer trial reports a 46% response rate; FDA filing planned - Stock Titan
ETFs Investing in PMV Pharmaceuticals, Inc. Stocks - TradingView
PMV (PMVP) Watch: Moves 1.15% Higher to $1.31; Price Context: Price Remains Between $1.24 Support and $1.38 Resistance in the Latest SessionValue Factor - vinanet.vn
PMV (PMVP) Latest Quarter: The Available Earnings Metric Delivers a Beat in the Latest Reading; Closing Move: The Stock Records a 3.23% Increase on the DayAnalyst Coverage Count - vinanet.vn
PMV Pharmaceuticals (PMVP) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
PMV Pharmaceuticals (NASDAQ:PMVP) Posts Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat
PMV Pharmaceuticals Releases Q2 2026 Financial Results - AlphaStreet
Form 8K Pmv Pharmaceuticals Inc For: 14 August By Investing.com - Investing.com Canada
PMV Pharmaceuticals Reports Second Quarter 2026 Financial Results and Corporate Highlights - The Manila Times
PMV Pharma Reports $18.1 Million Second-Quarter Net Loss - Quiver Quantitative
PMV Pharmaceuticals (PMVP) flags going-concern risk as rezatapopt advances toward NDA - Stock Titan
PMVP: Net loss narrowed, but liquidity concerns persist as rezatapopt advances toward NDA submission - TradingView
Press Release: PMV Pharmaceuticals Reports Second Quarter 2026 Financial Results and Corporate Highlights - Moomoo
PMV Pharmaceuticals Inc (PMVP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
PMV Pharmaceuticals Inc (PMVP) Stock News Today - TradingKey
PMVP Q2'26 Earnings: EPS estimate is (0.39) USD - TradingView
PMV Pharmaceuticals Inc expected to post a loss of 39 cents a shareEarnings Preview - TradingView
PMV Pharmaceuticals (PMVP) Projected to Announce Earnings on Thursday - MarketBeat
PMV Pharmaceuticals Inc (PMVP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Sio Capital discloses 4.94% PMV Pharmaceuticals (PMVP) stake below 5% threshold - Stock Titan
PMV Pharmaceuticals Inc (PMVP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
PMV Pharmaceuticals Inc (PMVP) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
PMV Pharmaceuticals Inc (PMVP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
PMV Pharmaceuticals Inc (PMVP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
PMVP|PMV Pharmaceuticals Inc|Price:1.140|Chg%:+0.020 - TradingKey
PMV Pharmaceuticals Inc (PMVP) Earnings Date & Reports & Earnings News - TradingKey
TradingKey - TradingKey
PMV Pharmaceuticals Inc (PMVP) Valuation: PE, PB & Fair Value Analysis - TradingKey
PMV Pharmaceuticals Inc (PMVP) Institutional Confidence - TradingKey
PMV Pharmaceuticals Inc (PMVP) Income Statement - TradingKey
PMVP|PMV Pharmaceuticals Inc|Price:1.240|Chg%:-0.090 - TradingKey
PMV Pharmaceuticals Inc (PMVP) Cash Flow - TradingKey
PMV Pharmaceuticals Inc (PMVP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
PMVP|PMV Pharmaceuticals Inc|Price:1.180|Chg%:-0.060 - TradingKey
PMVP|PMV Pharmaceuticals Inc|Price:1.210|Chg%:-0.010 - TradingKey
PMV Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:PMVP - TradingView
ArrowMark Colorado Holdings LLC Reduces Stake in PMV Pharmaceuti - GuruFocus
ArrowMark Colorado Holdings LLC Reduces Stake in PMV Pharmaceuticals Inc - GuruFocus
PMV Pharmaceuticals (PMVP) Declines 7.86% as Stock Tests Key Support LevelsPositive Gamma - vinanet.vn
PMV Pharmaceuticals (PMVP) Holds Steady at $1.42 as Trading Range TightensBreakout Confirmation - vinanet.vn
RANI Stock Price and Chart — NASDAQ:RANI - TradingView
PMV Pharmaceuticals (PMVP) Holds Steady Near Support as Consolidation ContinuesStraddle Setup - DonanımHaber
ArrowMark Colorado Holdings (PMVP) holds 3.67% stake in PMV Pharmaceuticals - Stock Titan
PMV Pharmaceuticals Coverage Assumed by Ladenburg Thalmann at Buy - Moomoo
PMV Pharmaceuticals Price Target Announced at $3.00/Share by Ladenburg Thalmann - Moomoo
PMV Pharmaceuticals outlines its cancer drug pipeline as shares trade quietly - Ad-hoc-news.de
PMV Pharmaceuticals (PMVP) upgraded to buy: Here's why - MSN
PMV Pharmaceuticals holds the focus as investors await the next catalyst. - Ad-hoc-news.de
July 2026's Spotlight On Promising Penny Stocks - Sahm
PMV Pharmaceuticals Q1 2026 Earnings: EPS Beat on Cost Control as Pre-Revenue Biotech Advances PipelineFinal Results - dars.gov.et
Enterprise value to EBITDA forward of PMV Pharmaceuticals, Inc. – NASDAQ:PMVP - TradingView
Price to earnings forward of PMV Pharmaceuticals, Inc. – NASDAQ:PMVP - TradingView
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):